krypton has been researched along with Angiogenesis, Pathologic in 36 studies
Krypton: A noble gas that is found in the atmosphere. It has the atomic symbol Kr, atomic number 36, atomic weight 83.80, and has been used in electric bulbs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether argon green laser (AGL) or krypton red laser (KRL) is superior for the treatment of well-defined extrafoveal choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD) after 3 years of follow-up." | 9.08 | Argon green vs. krypton red laser photocoagulation for extrafoveal choroidal neovascularization secondary to age-related macular degeneration: 3-year results of a multicentre randomized trial. Canadian Ophthalmology Study Group. ( Ballantyne, M; Cruess, AF; Willan, AR, 1996) |
| "This multicenter randomized controlled clinical trial performed in Canada was designed to determine whether krypton red laser or argon green laser is superior for treatment of choroidal neovascularization located between 200 and 2500 microns from the center of the foveal avascular zone in patients with age-related macular degeneration." | 9.07 | Argon green vs krypton red laser photocoagulation of extrafoveal choroidal neovascular lesions. One-year results in age-related macular degeneration. The Canadian Ophthalmology Study Group. ( , 1993) |
| "The Ocular Histoplasmosis Study-Krypton Laser is a multicenter controlled clinical trial designed to determine whether krypton red laser photocoagulation is of value in preventing visual acuity loss in eyes with ocular histoplasmosis that have either choroidal neovascularization 1 to 199 micron from the center of the foveal avascular zone (FAZ) or choroidal neovascularization 200 micron or further from the FAZ center with blood and pigment extending within 200 micron of the FAZ center." | 9.06 | Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Macular Photocoagulation Study Group. ( , 1987) |
| "To investigate the association between high anisometropia and the area of choroidal neovascularization (CNV) induced by krypton laser in guinea pigs and better understand the pathogenesis and prevention of myopic CNV." | 7.78 | Study of krypton laser-induced choroidal neovascularization in a Guinea pig model of high anisometropia. ( Jiang, W; Kang, Z; Liang, L; Liu, X; Tian, N; Wang, J; Zhang, Q, 2012) |
| "Krypton red (647 nm) laser photocoagulation may offer distinct advantages in the treatment of branch retinal vein occlusion (BRVO), particularly in eyes with extensive intraretinal hemorrhage or in the presence of media opacities such as vitreous hemorrhage or cataract." | 7.67 | Krypton red laser photocoagulation for branch retinal vein occlusion. ( Olk, RJ; Roseman, RL, 1987) |
| "To determine whether argon green laser (AGL) or krypton red laser (KRL) is superior for the treatment of well-defined extrafoveal choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD) after 3 years of follow-up." | 5.08 | Argon green vs. krypton red laser photocoagulation for extrafoveal choroidal neovascularization secondary to age-related macular degeneration: 3-year results of a multicentre randomized trial. Canadian Ophthalmology Study Group. ( Ballantyne, M; Cruess, AF; Willan, AR, 1996) |
| "This multicenter randomized controlled clinical trial performed in Canada was designed to determine whether krypton red laser or argon green laser is superior for treatment of choroidal neovascularization located between 200 and 2500 microns from the center of the foveal avascular zone in patients with age-related macular degeneration." | 5.07 | Argon green vs krypton red laser photocoagulation of extrafoveal choroidal neovascular lesions. One-year results in age-related macular degeneration. The Canadian Ophthalmology Study Group. ( , 1993) |
| "The Ocular Histoplasmosis Study-Krypton Laser is a multicenter controlled clinical trial designed to determine whether krypton red laser photocoagulation is of value in preventing visual acuity loss in eyes with ocular histoplasmosis that have either choroidal neovascularization 1 to 199 micron from the center of the foveal avascular zone (FAZ) or choroidal neovascularization 200 micron or further from the FAZ center with blood and pigment extending within 200 micron of the FAZ center." | 5.06 | Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Macular Photocoagulation Study Group. ( , 1987) |
| "To investigate the association between high anisometropia and the area of choroidal neovascularization (CNV) induced by krypton laser in guinea pigs and better understand the pathogenesis and prevention of myopic CNV." | 3.78 | Study of krypton laser-induced choroidal neovascularization in a Guinea pig model of high anisometropia. ( Jiang, W; Kang, Z; Liang, L; Liu, X; Tian, N; Wang, J; Zhang, Q, 2012) |
| "Fifty-one eyes with senile macular degeneration and a well-defined subretinal neovascular membrane located within 250 microns from the center of the foveal avascular zone were treated with krypton red laser photocoagulation." | 3.67 | Krypton red laser photocoagulation of subretinal neovascular membranes located within the foveal avascular zone. ( Annesley, WH; Decker, WL; Grabowski, WM, 1984) |
| "A prospective study of 78 patients, treated with krypton red laser (KRL) photocoagulation, who had senile macular degeneration (SMD) and subretinal neovascular membranes (SRNVM) located within 200u of the center of the foveal avascular zone (FAZ), was undertaken to determine if complete eradication of the SRNVM would minimize the resultant foveal scar size and retain the maximal useful functional vision as compared to untreated fellow eyes with a disciform scar." | 3.67 | Vision parameters in krypton and laser photocoagulation of subfoveal neovascular membranes. ( Donoso, LA; Edmonds, SE; Goldberg, RE; Magargal, LE; Melrose, MA, 1985) |
| "The eye of a patient with age-related macular degeneration was treated with krypton laser photocoagulation and later studied histopathologically." | 3.67 | Subretinal new vessels after krypton laser photocoagulation. ( Bindley, C; Kim, YM; Myers, FL; Wallow, IH, 1985) |
| "Krypton red (647 nm) laser photocoagulation may offer distinct advantages in the treatment of branch retinal vein occlusion (BRVO), particularly in eyes with extensive intraretinal hemorrhage or in the presence of media opacities such as vitreous hemorrhage or cataract." | 3.67 | Krypton red laser photocoagulation for branch retinal vein occlusion. ( Olk, RJ; Roseman, RL, 1987) |
| "The visual results and recurrence rates in treated extrafoveal NVMs of 70 patients with AMD and 21 patients with OHS were similar to those reported by the Macular Photocoagulation Study Group, in which all treated patients received argon blue-green laser photocoagulation after the administration of retrobulbar anesthesia." | 2.66 | Laser treatment for choroidal neovascularization outside randomized clinical trials. ( Alexander, MF; Chamberlin, JA; Fine, SL; Jost, BF; Maguire, MG; Murphy, RP, 1988) |
| "Krypton treated eyes also demonstrated a higher prevalence of ILM wrinkling in eyes with POHS (3/12, 25%) than in eyes with AMD (2/19, 10." | 1.27 | Internal limiting membrane wrinkling after argon and krypton laser photocoagulation of choroidal neovascularization. ( Folk, JC; Han, DP, 1986) |
| "Krypton was transmitted better through intact erythrocytes than argon." | 1.27 | Experiments on the absorption of argon and krypton laser by blood. ( Folk, JC; Kleiber, PD; Shortt, SG, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (86.11) | 18.7374 |
| 1990's | 4 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (2.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, J | 1 |
| Jiang, W | 1 |
| Kang, Z | 1 |
| Liang, L | 1 |
| Liu, X | 1 |
| Tian, N | 1 |
| Zhang, Q | 1 |
| Decker, WL | 3 |
| Grabowski, WM | 2 |
| Annesley, WH | 3 |
| Coscas, G | 4 |
| Soubrane, G | 3 |
| Koenig, F | 2 |
| Sales, J | 1 |
| Bernard, JA | 1 |
| Caumon, C | 1 |
| Hamard, H | 1 |
| Sabates, FN | 1 |
| Lee, KY | 1 |
| Ziemianski, MC | 1 |
| Singerman, LJ | 1 |
| Smiddy, WE | 3 |
| Fine, SL | 4 |
| Quigley, HA | 3 |
| Hohman, RM | 2 |
| Addicks, EA | 1 |
| Binaghi, M | 1 |
| Willan, AR | 1 |
| Cruess, AF | 1 |
| Ballantyne, M | 1 |
| Jampol, LM | 1 |
| Tielsch, J | 1 |
| Hawkins, BS | 1 |
| Maguire, MG | 2 |
| Gole, GA | 1 |
| Melrose, MA | 1 |
| Magargal, LE | 1 |
| Donoso, LA | 1 |
| Goldberg, RE | 1 |
| Edmonds, SE | 1 |
| Olk, RJ | 2 |
| Burgess, DB | 1 |
| Wallow, IH | 1 |
| Myers, FL | 1 |
| Kim, YM | 1 |
| Bindley, C | 1 |
| Shah, HG | 1 |
| Mansour, AM | 1 |
| Feldman, EL | 1 |
| Pournaras, CJ | 1 |
| Malthieu, D | 1 |
| Turut, P | 1 |
| Isorni, MC | 1 |
| Bego, B | 1 |
| Han, DP | 1 |
| Folk, JC | 2 |
| Roseman, RL | 1 |
| Jost, BF | 1 |
| Alexander, MF | 1 |
| Chamberlin, JA | 1 |
| Murphy, RP | 1 |
| Patz, A | 1 |
| Dunkelberger, GR | 1 |
| Frank, RN | 1 |
| Das, A | 1 |
| Weber, ML | 1 |
| Johnson, R | 1 |
| Schatz, H | 1 |
| Shortt, SG | 1 |
| Kleiber, PD | 1 |
| Watzke, RC | 2 |
| Morse, PH | 1 |
| Dunkelberger, G | 1 |
| Little, HL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000158] | Phase 3 | 0 participants | Interventional | 1979-02-28 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for krypton and Angiogenesis, Pathologic
| Article | Year |
|---|---|
[Subretinal neovascularization in senile macular degeneration].
Topics: Aged; Aging; Argon; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Krypton; Laser Thera | 1984 |
5 trials available for krypton and Angiogenesis, Pathologic
| Article | Year |
|---|---|
[Krypton lasers in ophthalmology. Initial experimental and clinical trials].
Topics: Aged; Animals; Clinical Trials as Topic; Cornea; Eye Diseases; Female; Humans; Krypton; Laser Therap | 1981 |
Argon green vs krypton red laser photocoagulation of extrafoveal choroidal neovascular lesions. One-year results in age-related macular degeneration. The Canadian Ophthalmology Study Group.
Topics: Argon; Choroid; Female; Fluorescein Angiography; Fovea Centralis; Humans; Krypton; Laser Coagulation | 1993 |
Argon green vs. krypton red laser photocoagulation for extrafoveal choroidal neovascularization secondary to age-related macular degeneration: 3-year results of a multicentre randomized trial. Canadian Ophthalmology Study Group.
Topics: Aged; Argon; Choroid; Female; Humans; Krypton; Laser Therapy; Light Coagulation; Macular Degeneratio | 1996 |
Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
Topics: Choroid; Clinical Trials as Topic; Eye Diseases; Fluorescein Angiography; Histoplasmosis; Humans; Kr | 1987 |
Laser treatment for choroidal neovascularization outside randomized clinical trials.
Topics: Argon; Choroid; Clinical Trials as Topic; Follow-Up Studies; Humans; Krypton; Laser Therapy; Light C | 1988 |
30 other studies available for krypton and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Study of krypton laser-induced choroidal neovascularization in a Guinea pig model of high anisometropia.
Topics: Animals; Anisometropia; Choroidal Neovascularization; Coloring Agents; Fundus Oculi; Guinea Pigs; In | 2012 |
Krypton red laser photocoagulation of subretinal neovascular membranes located within the foveal avascular zone.
Topics: Aged; Female; Follow-Up Studies; Humans; Krypton; Laser Therapy; Lasers; Macular Degeneration; Male; | 1984 |
Complications of krypton red laser photocoagulation to subretinal neovascular membranes.
Topics: Choroid; Humans; Krypton; Laser Therapy; Lasers; Neovascularization, Pathologic; Retinal Detachment; | 1984 |
[Krypton or argon laser? Differences for the treatment of submacular neovessels. Theoretical considerations].
Topics: Argon; Choroid; Humans; Krypton; Laser Therapy; Macula Lutea; Neovascularization, Pathologic | 1981 |
Red krypton laser photocoagulation in ocular histoplasmosis.
Topics: Adolescent; Adult; Evaluation Studies as Topic; Eye Diseases; Female; Histoplasmosis; Humans; Krypto | 1983 |
Total argon versus krypton versus partial laser photocoagulation for choroidal neovascularization in the presumed ocular histoplasmosis syndrome.
Topics: Argon; Choroid; Eye Diseases; Fluorescein Angiography; Histoplasmosis; Humans; Krypton; Laser Therap | 1983 |
The effects of red krypton and green argon laser on the foveal region. A clinical and experimental study.
Topics: Animals; Argon; Choroid; Fovea Centralis; Krypton; Lasers; Macula Lutea; Microscopy, Electron; Neova | 1983 |
Comparison of krypton and argon laser photocoagulation. Results of stimulated clinical treatment of primate retina.
Topics: Animals; Argon; Choroid; Hyperplasia; Krypton; Laser Therapy; Lasers; Macaca fascicularis; Macula Lu | 1984 |
[Effects of red krypton and monochromatic green argon lasers in the foveal region. A clinical and experimental study].
Topics: Animals; Argon; Follow-Up Studies; Haplorhini; Humans; Krypton; Laser Therapy; Lasers; Macular Degen | 1984 |
Race, macular degeneration, and the Macular Photocoagulation Study.
Topics: Argon; Choroid Plexus; Clinical Trials as Topic; Humans; Krypton; Laser Therapy; Light Coagulation; | 1992 |
Krypton Laser photocoagulation for neovascular lesions of age-related macular degeneration.
Topics: Aging; Humans; Krypton; Laser Therapy; Light Coagulation; Macular Degeneration; Neovascularization, | 1991 |
Massive choroidal haemorrhage as a complication of krypton red laser photocoagulation for disciform degeneration.
Topics: Aged; Choroid; Hemorrhage; Humans; Krypton; Laser Therapy; Lasers; Macular Degeneration; Male; Neova | 1985 |
Vision parameters in krypton and laser photocoagulation of subfoveal neovascular membranes.
Topics: Aged; Female; Fluorescein Angiography; Humans; Krypton; Laser Therapy; Macular Degeneration; Male; M | 1985 |
Treatment of recurrent juxtafoveal subretinal neovascular membranes with krypton red laser photocoagulation.
Topics: Adult; Aged; Eye Diseases; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Hist | 1985 |
Subretinal new vessels after krypton laser photocoagulation.
Topics: Aged; Aging; Cicatrix; Fluorescein Angiography; Humans; Krypton; Light Coagulation; Macular Degenera | 1985 |
Krypton red laser photocoagulation of peripapillary subretinal neovascular membranes.
Topics: Aged; Fluorescein Angiography; Follow-Up Studies; Humans; Krypton; Laser Therapy; Lasers; Light Coag | 1986 |
Laser treatment of subretinal neovascularization.
Topics: Argon; Humans; Krypton; Laser Therapy; Lasers; Macular Degeneration; Methods; Neovascularization, Pa | 1986 |
[Lasers and senile macular degeneration].
Topics: Aged; Argon; Humans; Krypton; Laser Therapy; Macular Degeneration; Middle Aged; Neovascularization, | 1985 |
[Treatment of neovascular choroid membranes with the krypton laser].
Topics: Choroid; Humans; Krypton; Laser Therapy; Light Coagulation; Neovascularization, Pathologic | 1986 |
Internal limiting membrane wrinkling after argon and krypton laser photocoagulation of choroidal neovascularization.
Topics: Adult; Argon; Choroid; Eye Diseases; Histoplasmosis; Humans; Krypton; Light Coagulation; Macular Deg | 1986 |
Krypton red laser photocoagulation for branch retinal vein occlusion.
Topics: Edema; Evaluation Studies as Topic; Fluorescein Angiography; Humans; Krypton; Laser Therapy; Light C | 1987 |
Histopathology of the effects of tuneable dye laser on monkey retina.
Topics: Animals; Choroid; Coloring Agents; Krypton; Laser Therapy; Lasers; Light Coagulation; Macaca fascicu | 1988 |
A model of subretinal neovascularization in the pigmented rat.
Topics: Animals; Argon; Choroid; Krypton; Lasers; Light Coagulation; Male; Microscopy, Electron; Neovascular | 1989 |
Delayed choroidal vascular filling after krypton laser photocoagulation.
Topics: Aged; Choroid; Female; Fluorescein Angiography; Humans; Krypton; Laser Therapy; Lasers; Macula Lutea | 1985 |
Experiments on the absorption of argon and krypton laser by blood.
Topics: Adult; Animals; Argon; Diabetic Retinopathy; Hemoglobinometry; Humans; Krypton; Laser Therapy; Laser | 1985 |
Laser treatment of macular disease: patient and laser selection.
Topics: Aged; Argon; Female; Humans; Krypton; Laser Therapy; Light Coagulation; Macula Lutea; Male; Neovascu | 1985 |
Laser treatment of macular disease: procedure and follow-up.
Topics: Argon; Follow-Up Studies; Humans; Krypton; Laser Therapy; Macula Lutea; Neovascularization, Patholog | 1985 |
Argon vs krypton laser lesions: is the wavelength more important than the power.
Topics: Adult; Aged; Argon; Evaluation Studies as Topic; Female; Fluorescein Angiography; Fundus Oculi; Huma | 1985 |
Simulated treatment of recurrent choroidal neovascularization in primate retina. Comparative histopathologic findings.
Topics: Animals; Argon; Choroid; Fovea Centralis; Krypton; Laser Therapy; Lasers; Macaca fascicularis; Neova | 1985 |
Treatment of proliferative diabetic retinopathy. Long-term results of argon laser photocoagulation.
Topics: Adult; Argon; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Ischemia; Krypton; Laser Ther | 1985 |